According to the latest data from the Hong Kong Stock Exchange, Morgan Stanley increased its position in NOVOSENSE (02676) on June 25th.
The financial institution purchased 105,836 shares at an average price of approximately HK$221.92 per share.
The total consideration for this transaction amounted to roughly HK$23.4871 million.
Following this acquisition, Morgan Stanley's latest shareholding stands at about 1.6538 million shares, representing an 8.22% stake in the company.